Cancer patients treated with sunitinib or sorafenib have suf…
Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination
Article, Chapter
Authors:
S.F. Mulder
Publication:
Volume:17,
Page(s):4541
Published:
2011
We were unable to find direct full text links for this item.